EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Impact of DCM-Causing Genetic Background on Long-Term Response to Cardiac Resynchronization Therapy

Matteo Dal Ferro, Alessia Paldino, Caterina Gregorio, Riccardo Bessi, Denise Zaffalon, Giulia De Angelis, Giovanni Maria Severini, Davide Stolfo, Marta Gigli, Francesca Brun, Laura Massa, Renata Korcova und 6 weitere

JACC: Clinical Electrophysiology · 2024

DOI: 10.1016/j.jacep.2024.03.019 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JACC: Clinical Electrophysiology, 2024. Verfasst von Matteo Dal Ferro und 17 weiteren Autor:innen. Beteiligte Einrichtung: Cardiovascular Department, Azienda Sanitaria Universitaria Giuliano Isontina (ASUGI), University of Trieste, Trieste, Italy. Member of the European R…. Hauptthemen laut MEDLINE: Cardiac Resynchronization Therapy, Cardiomyopathy, Dilated, Ventricular Remodeling. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NHLBI NIH HHS, NCATS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Patients with nonischemic dilated cardiomyopathy (DCM), severe left ventricular (LV) dysfunction, and complete left bundle branch block benefit from cardiac resynchronization therapy (CRT). However, a large heterogeneity of response to CRT is described. Several predictors of response to CRT have been identified, but the role of the underlying genetic background is still poorly explored. OBJECTIVES: In the present study, the authors sought to define differences in LV remodeling and outcome prediction after CRT when stratifying patients according to the presence or absence of DCM-causing genetic background. METHODS: From our center, 74 patients with DCM subjected to CRT and available genetic testing were retrospectively enrolled. Carriers of causative monogenic variants in validated DCM-causing genes, and/or with documented family history of DCM, were classified as affected by genetically determined disease (GEN+DCM) (n = 25). Alternatively, by idiopathic dilated cardiomyopathy (idDCM) (n = 49). The primary outcome was long-term LV remodeling and prevalence of super response to CRT (evaluated at 24-48 months after CRT); the secondary outcome was heart failure-related death/heart transplant/LV assist device. RESULTS: GEN+DCM and idDCM patients were homogeneous at baseline with the exception of QRS duration, longer in idDCM. The median follow-up was 55 months. Long-term LV reverse remodeling and the prevalence of super response were significantly higher in the idDCM group (27% in idDCM vs 5% in GEN+DCM; P = 0.025). The heart failure-related death/heart transplant/LV assist device outcome occurred more frequently in patients with GEN+DCM (53% vs 24% in idDCM; P = 0.028). CONCLUSIONS: Genotyping contributes to the risk stratification of patients with DCM undergoing CRT implantation in terms of LV remodeling and outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cardiac Resynchronization TherapyCardiomyopathy, DilatedVentricular RemodelingHumansFemaleMaleMiddle AgedRetrospective StudiesAgedTreatment OutcomeHeart FailureAdultVentricular Dysfunction, LeftBundle-Branch Block

Stichwörter der Autor:innen

LBBBLBBBICMPLV remodelingcardiac resynchronization therapydilated cardiomyopathygenetic backgroundsuper responder

Autor:innen und Institutionen

  • Cardiovascular Department, Azienda Sanitaria Universitaria Giuliano Isontina (ASUGI), University of Trieste, Trieste, Italy. Member of the European Reference Network for rare, low-prevalence, or complex diseases of the…
  • Biostatistics Unit, University of Trieste, Trieste, Italy; Aging Research Center, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet and Stockholm University, Stockholm, Sweden.
  • Aging Research Center, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet and Stockholm University, Stockholm, Sweden; Cardiology Department, Azienda Sanitaria Universitaria Friuli Occidentale…
  • Institute for Maternal and Child Health-IRCCS, Burlo Garofolo, Trieste, Italy.

Förderung

  • NHLBI NIH HHS
  • NCATS NIH HHS

Zitieren

APA

Dal Ferro, M., Paldino, A., Gregorio, C., Bessi, R., Zaffalon, D., De Angelis, G., Severini, G. M., Stolfo, D., Gigli, M., Brun, F., Massa, L., Korcova, R., Salvatore, L., Bianco, E., Mestroni, L., Merlo, M., Zecchin, M., & Sinagra, G. (2024). Impact of DCM-Causing Genetic Background on Long-Term Response to Cardiac Resynchronization Therapy. JACC: Clinical Electrophysiology. https://doi.org/10.1016/j.jacep.2024.03.019

Vancouver

Dal Ferro M, Paldino A, Gregorio C, Bessi R, Zaffalon D, De Angelis G, et al. Impact of DCM-Causing Genetic Background on Long-Term Response to Cardiac Resynchronization Therapy. JACC: Clinical Electrophysiology. 2024. doi:10.1016/j.jacep.2024.03.019

BibTeX
@article{DalFerro2024,
  author = {Dal Ferro, Matteo and Paldino, Alessia and Gregorio, Caterina and Bessi, Riccardo and Zaffalon, Denise and De Angelis, Giulia and Severini, Giovanni Maria and Stolfo, Davide and Gigli, Marta and Brun, Francesca and Massa, Laura and Korcova, Renata and Salvatore, Luca and Bianco, Elisabetta and Mestroni, Luisa and Merlo, Marco and Zecchin, Massimo and Sinagra, Gianfranco},
  title = {Impact of DCM-Causing Genetic Background on Long-Term Response to Cardiac Resynchronization Therapy},
  journal = {JACC: Clinical Electrophysiology},
  year = {2024},
  doi = {10.1016/j.jacep.2024.03.019}
}
Kostenlos starten →